1. Каркищенко Н.Н., Грачев С. В. Руководство по лабораторным животным и альтернативным моделям в биомедицинских исследованиях: учебное пособие для системы медицинского и фармацевтического послевузовского образования. - М.: Профиль, 2010. - 358 с.
2. Сидорчук А.А., Глушков А. А. Инфекционные болезни лабораторных животных. Учебное пособие, 1-е изд. - М.: Лань, 2009. -128 с.
3. Allan R.N., Rhodes J. M., Hanauer S. B. (eds) Inflammatory bowel diseases, 3rd edn. - London: Churchill Livingstone, 1997. - P. 863.
4. Barnich N. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease / Barnich N., Carvalho F. A., Glasser A. L. et al. //J Clin Invest. - 2007. - № 6 (117). - P. 1566-1574.
5. Carvalho F. A. Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. // J Exp Med. - 2009. - № 10 (206). - P. 2179-89.
6. Corridonia D. Inflammatory bowel disease / Corridonia D., Arseneau K. O., Cominellia F. // Immunology Letters. - 2014. - № 2 (161). - P. 231-235.
7. Craven M. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn’s disease / Craven M., Egan C. E., Dowd S. E. et al. // PLoS One. - 2012. - № 7 (7). - e41594. https://doi.org/10.1371/journal.pone.0041594.
8. Eckburg P. B. Diversity of the human intestinal microbial flora / Eckburg P. B., Bik E. M., Bernstein C. N. et al. // Science. - 2005. - № 308 (5728). - P. 1635-1638.
9. Gevers D. The treatment-naive microbiome in new-onset Crohn’s disease / Gevers D., Kugathasan S., Denson L. A. et al. // Cell Host Microbe. - 2014. - № 3(15) - P. 382-392.
10. Golovics P. A. Inflammatory bowel disease course in Crohn’s disease: Is the natural history changing? / Golovics P. A., Mandel M. D., Lovasz B. D. et al. // World J Gastroenterol. - 2014. - № 12 (20). - P. 3198-3207.
11. Hale L. P. A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features / Hale L. P., Greer P. K. // PLoS ONE. - 2012. -№ 7 (7). - https://doi.org/97.doi:10.1371/journal.pone.0041797.
12. Kojima R. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis / Kojima R., Kuroda S., Ohkishi T. et al. // J Pharmacol Sci. - 2004. - № 3 (96). - P. 307-313.
13. Laroux F. S. Regulation of chronic colitis in athymic nu/nu (nude) mice / Laroux F. S., Norris H. H., Houghton J. et al. // Int Immunol. - 2004. - № 1 (16). - P. 77-89.
14. Ley R. E. Obesity alters gut microbial ecology / Ley R. E., Bäckhed F., Turnbaugh P. et al. // Proc Natl Acad Sci U S A. -2005. - № 31(102). - P. 11070-11075.
15. Liao S. L. Maturation ofToll-like receptor 1-4 responsiveness during early life / Liao S. L., Yeh K. W., Lai S. H. et al. // Early Hum Dev. - 2013. - № 7 (89). - P. 473-478.
16. Louis E. From evidence-based medicine to personalized medicine in Crohn’s disease / Louis E., Reenaers C., Van Kemseke C. et al. // Rev Med Liege. - 2015. - № 5 (70). - P. 316-320.
17. Mahler M. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis / Mahler M., Bristol I. J., Leiter E. H. et al. // American Journal of Physiology. -1998. - № 3 (274). - P. 544-551.
18. Martinez-Medina M. Escherichia coli in chronic inflammatory bowel diseases: an update on adherent invasive Escherichia coli pathogenicity / Martinez-Medina M., Garcia-Gil L.J. // World J Gastrointest Pathophysiol. - 2014. - № 3(5). - P. 213-227.
19. Mizoguchi A. Animal models of inflammatory bowel disease. Progress in molecular biology and translational science // Prog Mol Biol Transl Sci. - 2012. - № 105. - P. 263-320.
20. Morampudi V. DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat / Morampudi V., Bhinder G., Wu X. et al. // J. Vis. Exp. - 2014. - № 84. - e51297. https://doi.org/10.3791/51297.
21. Nguyen T. L. A. How informative is the mouse for human gut microbiota research? / Nguyen T. L.A., Vieira-Silva S., Liston A., Raes J. // Dis Model Mech. - 2015. - № 1(8). - P. 1-16.
22. Pizarro T. T. SAMP1/YitFc mouse strain: a spontaneous model of Crohn’s disease-like ileitis / Pizarro T. T., Pastorelli L., Bamias G. et al. // Inflammatory bowel diseases. - 2011. - № 12 (17). - P. 2566-2584.
23. Powrie F. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD 45RBhi CD 4+ T cells / Powrie F., Leach M. W., Mauze S. et al. // Immunity. - 1994. - № 1(7). - P. 553-562.
24. Randhawa P. K. A review on chemical-induced inflammatory bowel disease models in rodents / Randhawa P. K., Singh K., Singh N. // Korean J Physiol. - 2014. - № 4 (18). - P. 279-88.
25. Reingold L. Development of a peptidoglycan-polysaccharide murine model of Crohn’s disease: effect of genetic background / Reingold L., Rahal K., Schmiedlin-Ren P. et al. // Inflamm Bowel Dis. - 2013. - № 6 (19). - P. 1238-1244.
26. Remond D. Intestinal inflammation increasesgastrointestinal threonine uptake and mucin synthesis in enterally fed minipigs / Remond D., Buffiere C., Godin J. et al. // J. Nutr. - 2009. -№ 4 (139). - P. 720-726.
27. Roulis M. Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology / Roulis M., Armaka M., Manoloukos M. et al. // PNAS. - 2011. - № 13 (108). - P. 5396-5401.
28. Treuting P. M. Lower gastrointestinal tract / Treuting P. M., Dintzis S. M. // Comparative anatomy and histology. A mouse and human atlas, 1st edn. - 2012. - P. 177-192.
29. van Mierlo G. J. D. The minipig as an alternative non-rodent model for immunogenicity testing using the TNFα blockers adalimumab and infliximab / van Mierlo G. J.D., Cnubben N. H.P., Wouters D. et al. // J Immunotoxicol. - 2014. - № 1 (11). - P. 62-71.